YOLFTbeta
06

Hwail Pharmaceutical Co.Ltd

061250 · KQ · Healthcare / Drug Manufacturers - Specialty & Generic

5,450.00KRW+50.00 (+0.93%)

Price History

Full chart

Market Stats

Previous Close5,400.00
Open5,400.00
Day Range5,280.00 – 5,480.00
52-Week Range6,210.00 – 12,500.00
Volume2.29K
Market Cap56.82B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.16
50-Day Avg8,076.40
200-Day Avg9,217.85

About

Hwail Pharmaceutical Co.,Ltd. develops pharmaceutical raw materials in South Korea. It provides raw drug products, finished drug products, and functional health food raw material business. The company was founded in 1974 and is headquartered in Seongnam-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOKyung-sook Cho
  • Employees0
  • HeadquartersKorea Bio Park C-dong, Seongnam-si, South Korea, 13488, Korea
  • Websitehttps://www.hwail.com

Leadership

  • Kyung-sook ChoChief Executive Officer
  • Saeng-gyu SeoChief Executive Officer
  • Hye-Gyung WooDirector of Development and Director · b. 1964
  • Young-Hwan JeonSales Director and Director · b. 1960

Financials

Income Statement

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue78.10B91.83B94.17B96.10B106.13B111.52B102.46B102.07B108.74B123.61B106.99B132.05B122.54B119.76B100.82B
Growth (%)-+17.59%+2.54%+2.06%+10.43%+5.08%-8.12%-0.38%+6.54%+13.67%-13.45%+23.43%-7.20%-2.27%-15.82%
Cost of Revenue62.89B74.76B78.37B82.20B96.31B96.76B87.33B86.87B94.26B108.58B96.43B118.50B111.02B109.21B94.17B
Gross Profit--15.80B13.90B9.82B14.76B15.13B15.20B14.48B15.03B10.56B13.55B11.52B10.55B6.64B
Gross Margin--16.77%14.46%9.25%13.24%14.77%14.89%13.32%12.16%9.87%10.26%9.40%8.81%6.59%
Operating Expense--10.23B9.23B8.17B12.35B10.85B8.71B10.55B11.48B7.41B24.22B12.58B11.48B8.91B
Operating Income6.71B7.64B5.57B4.67B1.65B2.42B4.28B6.49B3.93B3.56B3.15B-10.66B-1.06B-924.32M-2.27B
Operating Margin8.59%8.32%5.91%4.86%1.56%2.17%4.18%6.36%3.62%2.88%2.95%-8.08%-0.87%-0.77%-2.25%
EBITDA------------6.09B6.08B9.71B1.32B
EBITDA Margin------------4.61%4.96%8.11%1.31%
Net Income4.69B5.06B4.21B4.13B5.45B6.38B2.67B5.08B3.19B2.81B2.84B-6.33B3.86B6.48B-233.01M
Net Income Margin6.00%5.51%4.47%4.30%5.14%5.72%2.60%4.97%2.94%2.27%2.66%-4.79%3.15%5.41%-0.23%
R&D439.60M529.00M661.90M565.50M429.70M390.57M---741.65M733.44M631.79M670.02M711.43M753.80M
R&D as % of Total Revenue0.56%0.58%0.70%0.59%0.40%0.35%---0.60%0.69%0.48%0.55%0.59%0.75%
Interest Expense000000000137.48M115.81M11.42M18.94M265.06M207.79M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.11%0.11%0.01%0.02%0.22%0.21%

Balance Sheet

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets98.73B113.14B123.02B122.92B140.27B128.62B123.90B123.41B139.40B169.68B194.15B185.60B186.00B215.61B213.16B
Total Liabilities29.24B30.92B36.71B33.85B41.33B28.76B25.72B22.16B19.97B12.82B12.49B10.02B11.55B12.19B6.29B
Total Equity69.49B82.22B86.31B89.07B98.94B99.86B98.18B101.25B119.43B156.86B181.66B175.57B174.45B203.42B206.87B
Cash3.93B8.47B8.26B4.27B3.79B8.16B922.00K1.27M720.00K124.00K673.00K438.00K279.00K54.11B61.47B
Total Debt-----13.74B12.40B7.09B6.26B6.54B-----

Cash Flow

Currency: KRW2006-12-312007-12-312008-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow---7.86B1.00B6.97B-2.78B-6.90B9.58B8.34B7.17B3.69B-201.69M20.09B-233.56M7.02B11.63B11.88B
Investing Cash Flow---1.55B--10.96B192.16M3.47B7.70B524.07M313.37M-3.71B-26.33B-36.78B9.84B19.74B-49.56B-
Financing Cash Flow----7.54B3.86B-1.41B3.80B-13.75B-3.36B-5.34B11.47B33.73B21.13B-4.04B-5.10B24.91B-
Capital Expenditure0005.32B7.72B9.18B1.41B1.06B413.00M513.62M1.55B1.09B4.68B2.47B10.39B2.10B34.63B3.99B
Free Cash Flow-------------4.88B17.62B-10.63B4.92B-23.00B7.88B
Dividends Paid---1.06B1.03B1.31B1.35B1.35B2.03B2.03B2.03B2.03B2.05B0----
FCF to OCF------------2420.42%87.70%4549.17%70.08%-197.69%66.37%
Dividend Paid to FCF-------------42.01%0.00%----

Earnings

Report DateAug 14, 2006Nov 14, 2006Feb 21, 2007May 8, 2008Aug 11, 2008Jun 3, 2009Sep 2, 2009Oct 19, 2009Mar 3, 2010Jun 2, 2010Sep 1, 2010Dec 1, 2010Mar 2, 2011Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016Jun 1, 2016Aug 16, 2016Nov 14, 2016Feb 20, 2017May 15, 2017Aug 11, 2017Nov 14, 2017Feb 7, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Mar 12, 2019May 29, 2019Aug 13, 2019Nov 14, 2019Feb 5, 2020May 13, 2020Aug 12, 2020Nov 12, 2020Mar 3, 2021May 14, 2021Aug 11, 2021Nov 18, 2021May 18, 2022Aug 12, 2022Nov 10, 2022Mar 1, 2023May 12, 2023Aug 16, 2023Nov 16, 2023May 10, 2024Aug 13, 2024Nov 14, 2024Apr 7, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate363.33396.67420.00378.03643.33293.33-540.00----------------------------------------------------------------
EPS Actual899.47368.40374.67460.00496.67456.67505.61506.67123.33296.67256.67351.08277.61420.75284.76320.18233.37249.22202.89437.31382.17418.11434.41102.0183.08262.60326.98167.12262.23184.89314.3881.95762.951316.0261.1412.71-48.2121.82-0.5634.659.7937.5139.9725.9221.73340.93203.3697.35142.96373.84164.4384.81-43.68133.2277.4748.68304.19338.72-818.60-777.15189.73116.11553.98180.03-75.9610.66720.1368.0246.17-61.2768.78519.87
Surprise147.56%-7.13%-10.79%21.68%-22.80%55.68%--6.17%----------------------------------------------------------------
TimingPre-marketPre-marketAfter-hoursAfter-hours-Pre-market-Pre-market--------------------------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market---------------------------

Key Statistics & Ratios

Market Cap56.82B
Enterprise Value-36.16B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.53
Price / Book0.25
Revenue (TTM)107.87B
Gross Profit (TTM)14.09B
EBITDA5.20B
Profit Margin1.78%
Operating Margin-3.73%
Return on Equity1.94%
Return on Assets1.05%
Shares Outstanding8.42M
Shares Float4.32M
Beta0.16
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20201×
41.67Dec 29, 2020
20191×
416.67Dec 27, 2019
20181×
500.00Dec 27, 2018
20171×
500.00Dec 27, 2017
20161×
500.00Dec 28, 2016
20151×
500.00Dec 29, 2015
20141×
333.33Dec 29, 2014
20131×
333.33Dec 27, 2013
20121×
333.33Dec 27, 2012
20111×
333.33Dec 28, 2011
20101×
333.33Dec 29, 2010
20081×
333.33Dec 29, 2008
20071×
500.00Dec 27, 2007
20061×
500.00Dec 27, 2006
20051×
500.00Dec 28, 2005
20041×
500.00Dec 29, 2004
20031×
500.00Dec 29, 2003
20021×
500.00Dec 27, 2002

Stock Splits

  • May 4, 20261:10
  • Mar 17, 2021959692:319897
  • Apr 7, 20052:1
  • Oct 24, 200221:10